HIGH-AFFINITY [H-3] PAROXETINE BINDING TO SEROTONIN UPTAKE SITES IN HUMAN-BRAIN TISSUE

被引：162

作者：

BACKSTROM, I ^{[1
]}

BERGSTROM, M ^{[1
]}

MARCUSSON, J ^{[1
]}

机构：

[1] UMEA UNIV,DEPT GERIATR MED,S-90187 UMEA,SWEDEN

来源：

BRAIN RESEARCH | 1989年 / 486卷 / 02期

关键词：

D O I：

10.1016/0006-8993(89)90511-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：261 / 268

页数：8

共 28 条

[1]

Azmitia E. C., 1987, PSYCHOPHARMACOLOGY 3, P61

[2] 5-HYDROXYTRYPTAMINE-SENSITIVE [H-3] IMIPRAMINE BINDING OF PROTEIN NATURE IN THE HUMAN-BRAIN .1. CHARACTERISTICS [J].

BACKSTROM, IT ;

MARCUSSON, JO .

BRAIN RESEARCH, 1987, 425 (01) :128-136

[3] QUANTITATIVE AUTORADIOGRAPHY OF [H-3]INDALPINE BINDING-SITES IN THE RAT-BRAIN .1. PHARMACOLOGICAL CHARACTERIZATION [J].

BENAVIDES, J ;

SAVAKI, HE ;

MALGOURIS, C ;

LAPLACE, C ;

MARGELIDON, C ;

DANIEL, M ;

COURTEIX, J ;

UZAN, A ;

GUEREMY, C ;

LEFUR, G .

JOURNAL OF NEUROCHEMISTRY, 1985, 45 (02) :514-520

[4] HIGH AND LOW AFFINITY [H-3]IMIPRAMINE BINDING-SITES IN CONTROL AND PARKINSONIAN BRAINS [J].

CASH, R ;

RAISMAN, R ;

PLOSKA, A ;

AGID, Y .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 117 (01) :71-80

[5] HIGH-AFFINITY AND LOW-AFFINITY BINDING-COMPONENTS FOR [H-3]IMIPRAMINE IN RAT CEREBRAL-CORTEX [J].

CONWAY, PG ;

BRUNSWICK, DJ .

JOURNAL OF NEUROCHEMISTRY, 1985, 45 (01) :206-209

[6]

DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364

[7] AMINERGIC SYSTEMS IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE [J].

DAMATO, RJ ;

ZWEIG, RM ;

WHITEHOUSE, PJ ;

WENK, GL ;

SINGER, HS ;

MAYEUX, R ;

PRICE, DL ;

SNYDER, SH .

ANNALS OF NEUROLOGY, 1987, 22 (02) :229-236

[8]

DUMBRILLEROSS A, 1983, MOL PHARMACOL, V23, P607

[9] CHARACTERIZATION OF [H-3] PAROXETINE BINDING TO RAT CORTICAL MEMBRANES [J].

HABERT, E ;

GRAHAM, D ;

TAHRAOUI, L ;

CLAUSTRE, Y ;

LANGER, SZ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (1-2) :107-114

[10] BINDING OF A SPECIFIC 5-HT UPTAKE INHIBITOR, [H-3]-LABELED NORZIMELIDINE, TO RAT-BRAIN HOMOGENATES [J].

HALL, H ;

ROSS, S ;

OGREN, SO ;

GAWELL, L .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 80 (2-3) :281-282

← 1 2 3 →